Existing horizon scanning activities could be strengthened to aid budget planning in the context of high upfront cost therapies such as gene therapies. International collaborations could be leveraged ...

The Office of Health Economics is delighted to host the Health Economists’ Study Group Summer Meeting, which will run from 30th June – 2nd July 2025. Founded in 1972, the Health Economists’ Study ...

The policy environment for rare disease and orphan medicines is complex and encompasses regulation, reimbursement, and ...

Measuring and valuing health outcomes is arguably what makes health economics such a unique and sometimes controversial discipline. The idea of putting a numerical value on an individual’s health ...

Notes: results ‘per person’ comprise all people with asthma in the UK, results ‘per year’ comprise all people using pMDIs (not limited to asthma). In relation to our secondary aim of exploring the ...

Alastair Fischer Ph.D. has had a long career in statistics, economics and public health. He has a BSc from the University of Adelaide majoring in Pure Mathematica and Statistics, a BEc from the ...

Chris is an expert in economic evaluation. His research focuses on significant methodological and policy challenges relating to the value of interventions and programmes for health. At OHE, Chris’s ...

Prof. Elizabeth Robinson is Director of the Grantham Research Institute on Climate Change and the Environment.

Julia joined OHE in August 2023 as a digital marketing coordinator. During her career, she gained experience in digital, social and event marketing while working with lifestyle, economic, and ...

Donor Investment Choices: Modeling the Value for Money of Investing in Product Development, Public Private Parnerships as Compared to Other Health Care and Non-Health Care Interventions ...